This New, FDA-Approved Skin Care Drug Could Help Over 7.5 Million People
Alleviating psoriasis
symptoms has been a difficult feat to achieve for decades, but with new
advances in the skin care industry, doctors are excited that a cure may
be closer than ever before.
While we still haven't reached a final
remedy yet, a new advancement in the treatment of psoriasis has people
super excited. Bryhali Lotion 0.01% is a new topical treatment that uses
an active ingredient called halobetasol to treat the condition. And as Allure
reports, Bryhali Lotion has just been approved by the Food and Drug
Administration, making doctors and patients alike excited to give the
new medication a try.
The
treatment, which is a “super-potent corticosteroid,” is used on
affected skin and is attained through a prescription. It works to calm
the inflamed skin
caused by plaque psoriasis—the most common form of psoriasis—which
often presents itself as dry, raised, red skin lesions covered with
silvery scales.
You May Also Like: An Injection to Erase Cellulite Might Be Coming Very Soon
Unlike
other psoriasis medications, Bryhali Lotion is proven to be safe for a
longer time period (8 weeks!) than its competitors. Most psoriasis drugs
are only considered safe for a two week period because they’ve been
proved to thin the skin with additional use, however, this didn’t happen
to users in clinical trials that tested Bryhali Lotion for the full
eight weeks.
"Bryhali
Lotion will help address an unmet need for many plaque psoriasis
patients," said Lawrence J. Green, M.D., a lead investigator on the
Bryhali Lotion Phase 3 studies and associate clinical professor of
Dermatology at George Washington University School of Medicine, in a press release. "Topical steroids
are the most frequently used treatment for psoriasis, but come with an
increased risk of adverse events and a duration of use limited to two to
four weeks. With Bryhali Lotion, I'm excited to offer my patients a
topical steroid option that can be used for up to eight weeks without
sacrificing tolerability, and with proven efficacy."
Possible side effects of
the treatment include burning, stinging, itching and dryness at the
application site, so be sure to talk to your doctor if you experience
any of these symptoms when using the product. Regardless of these side
effects, we can’t help but be excited about Bryhali Lotion's FDA
approval. Considering psoriasis affects 7.5 million people, it’s
possible this could make a big difference in a lot of lives.
Comments
Post a Comment